Loading...
Loading...
Contributors:
Dataset URI:
10.6084/m9.figshare.34741001.v1Influenza A virus (IAV) infection remains a pervasive global public health threat. Natural products are recognised as a valuable reservoir for the discovery and development of novel antiviral agents. This study investigated the anti-IAV activity and mechanisms of 11-Hydroxy-14-methoxy-18 (4→3)-abeo-abieta-3,8,11,13- tetraen-18-oic acid named Triptobenzene H (TPZH), a diterpenoid isolated from Tripterygium wilfordii. In IAV-infected MDCK cells, TPZH increased the viability of IAV-infected MDCK cells, limited ROS accumulation, and alleviated mitochondrial dysfunction. Mechanistically, TPZH targeted the viral replication stage, disrupting the IAV life cycle and reducing viral loads. Furthermore, in virus-stimulated macrophages, TPZH suppressed inflammatory protein expression and cytokine overproduction through inhibiting activation of MAPK and NF-κB signalling pathways. Collectively, TPZH exerts anti-influenza effects by blocking viral replication and alleviating virus-mediated inflammatory injury via modulation of macrophage-dependent immune responses. This study demonstrates that TPZH exhibits multi-target pharmacological properties and holds promising therapeutic potential for anti-influenza treatment.
Keyword(s):
Abietane diterpenoid; anti-influenza virus; Biochemistry; Biological Sciences not elsewhere classified; Biotechnology.
MeSH Term(s):
Grants and Funding:
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)